Pharma groups decry Covid-19 vaccine IP waiver ahead of Geneva conference – Endpoints News - Press release distribution to media in EMEA

If the World Trade Organization gets its way, an IP waiver deal for Covid-19 vaccines may be reached as soon as next week. But the critics keep piling up.

A handful of pharma advocacy and lobbying groups — including the International Federation of Pharmaceutical Manufacturers and Associations and the Washington Council on…

Source link

Pharma groups decry Covid-19 vaccine IP waiver ahead of Geneva conference – Endpoints News

UAE will be fertile ground for deep tech startups

Anthony Joshua to quit Sky Sports and join rival DAZN

RelatedPosts

Global Obesity Drugs Market valued at $2.3 billion (2022),

U.S. FDA proposes shift to annual COVID vaccine shots – PharmaLive

Vitamins Market See Huge Growth for New Normal by Top Key Companies:ABH Pharma, Aktiv Organic, Boli LLV, Melrob Group, Bayer AG, Makers Nutrition

Eye Health Supplement Market to See Booming Growth 2023-2030 | Pfizer, Inc., Bausch Health Companies Inc., Alcon Laboratories, Inc., Alliance Pharma PLC

Latest Post

UV Tape Market is expected to grow at a CAGR of 7.4 percent during the forecast period

CO2 Gas Sensor Market is expected to grow at a CAGR of 9.2 percent during the forecast period.

Recreation Club Market is expected to grow at a CAGR of 6.8 percent during the forecast period.

Methyl Palmitate Market is expected to grow at a CAGR of 5.2 percent during the forecast period

Bio-based Polyurethane Foam Market is expected to grow at a CAGR of 5.9 percent during the forecast period.

Subscribe to Our Newsletter

Browse by Category-

Share us